Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922958 · ClinicalTrials.gov registry record
Immunoparalysis in Acute Kidney Injury After Cardiac Surgery
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 60
- Enrollment target
NCT03922958: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT03922958 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03922958 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Infection and sepsis are common after acute kidney injury (AKI) and increase mortality. In this study, the investigators will determine whether patients with acute kidney injury after cardiac surgery have immunosuppression as judged by blood markers of immunoparalysis.
Primary Outcome
Patients with AKI will have a higher rate of immunoparalysis compared to those without AKI when immunoparalysis is identified by TNF levels after ex vivo endotoxin stimulation. As well as patients with AKI will have a higher rate of immunoparalysis compared to those without AKI when immunoparalysis is identified by monocyte HLA-DR (mHLA-DR) expression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2022-05-30 |
Why NCT03922958 stopped before completion
NCT03922958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03922958 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03922958 about?
NCT03922958 is a clinical study titled "Immunoparalysis in Acute Kidney Injury After Cardiac Surgery". Infection and sepsis are common after acute kidney injury (AKI) and increase mortality. In this study, the investigators will determine whether patients with acute kidney injury after cardiac surgery have immunosuppression as judged by blood markers of immunoparalysis.
What is the current status of trial NCT03922958?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2019-02-22. Estimated completion is 2022-05-30.
Who is sponsoring clinical trial NCT03922958?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI